Angiotensin-Based Pharmacotherapy versus Conventional Therapy for Systolic Hypertension

Article on - Efficacy and Safety of Angiotensin-Based Pharmacotherapy versus Conventional Therapy for the Management of Isolated Systolic Hypertension: A Meta-Analysis of Randomized Controlled Trials

International Journal of Clinical Pharmacology & Toxicology (IJCPT)ISSN 2167-910X

The angiotensin (AT) system is highly implicated in the pathophysiology of isolated systolic hypertension (ISH). Consequently, this meta-analysis was designed to quantitatively review the efficacy and safety of angiotensin (AT)-based regimens in comparison with conventional thiazide diuretics or calcium channel blockers (CCBs) for the management of ISH. MEDLINE and CENTRAL were searched for relevant randomized controlled trials (RCTs).

To read this article: http://scidoc.org/IJCPT-2167-910X-05-701.php
For more details: http://scidoc.org/clinical-pharmacology-and-toxicology.php